Special Report

Published in:
Volume 5 / Year 2016 / Issue 3

Competitive effects on the generics industry

Page: 144

Abstract: A study of the factors influencing generics makers’ decision on whether to enter a specific market found that firm size, market revenue and expected competition all had an effect.… Read More »

US FDA proposals for naming of biologicals and labelling of biosimilars

Page: 140-3

Abstract: There is considerable concern and debate over the naming of biologicals and labelling of biosimilars. To ensure that patients receive the safest and most effective treatment, it is paramount… Read More »

Go Back Print